GE urges customers to inspect MRI systems following FDA notice of potential injury

Citing possible employee error in how the magnetic rundown unit (MRU) is connected at certain sites, the FDA issued a Class I recall for all GE Healthcare MRIs with superconducting magnets and the company is urging customers to properly test their equipment.

The recall covers 25 different MRIs, including those under the Signa, Discovery and Optima brands, and affects 12,968 installed systems (5,708 of which are located in the U.S.).

“At certain sites, the MRU may not be connected to the magnet. In emergency situations, a disconnected MRU could delay removal of a ferrous object from the magnet, potentially resulting in life-threatening injuries,” read the recall notice. “The MRU must be connected to the magnet at all times.”

The FDA noted that last month, GE sent a letter to customers describing the issue and provided instructions on how to test that the MRU is properly connected.

The full list of affected systems and detailed preventative and testing procedures can be found here.

Evan Godt
Evan Godt, Writer

Evan joined TriMed in 2011, writing primarily for Health Imaging. Prior to diving into medical journalism, Evan worked for the Nine Network of Public Media in St. Louis. He also has worked in public relations and education. Evan studied journalism at the University of Missouri, with an emphasis on broadcast media.

Around the web

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.